Columns
- All
- Advanced Degrees
- Analyze This
- Back Page
- Clinically Speaking
- Deal Discussions
- Editorial
- Emerging Markets
- Executive Perspective
- FDA Watch
- Financial Analysis
- Getting Results
- I Mak
- India Report
- Lowe Down
- Managing Your Career
- Opinions & Best Practices
- PBOA News
- Pharma Beat
- Preclinical Outsourcing
- The BioPharm Insider
-
Know the Challenges of Biosimilar Manufacturing
Best practices for a competitive marketJerry Martin and Michiel Ultee 09.06.17
-
GMPs/GCPs
What are GMPs?
And why do we need them in contract work?Emil W. Ciurczak, DoraMaxx Consulting 09.06.17
-
-
Regulatory Affairs
FDARA and Beyond
In a few short years, PBOA establishes itself as a key industry resourceGil Roth, Pharma & Biopharma Outsourcing Association 09.06.17
-
Regulatory Affairs | Supply Chain
Supply Chain Risk Mitigation
Addressing the inherent risks in an increasingly fragmented supply chainNuala Calnan, Lachman Consultant Services 09.06.17
-
The Powers of Persuasion
Why do technical employees have difficulty being persuasive?David G. Jensen, Contributing Editor 09.06.17
-
Serialization
DSCSA Deadline Approaches
An expert panel will convene at Contract Pharma’s upcoming conference to discuss key serialization issues, challenges andTim Wright, Editor 09.06.17
-
Supply Chain
Marketing Code Round The Corner
Proposal to limit giveaways; offenders face product banS. Harachand, Contributing Editor 09.01.17
-
The Implicit Public Distrust of Drug Pricing Trends
Or, “Why Are My Drugs So Expensive?”Ben Locwin, Healthcare Science Advisors 07.18.17
-
QA/QC | Regulatory Affairs
India Frames Guidance for Drug Surveillance
Outsourcing PV functions to riseS. Harachand, Contributing Editor 07.18.17
-
Cytotoxics and High Potency Manufacturing
High Potency APIs: Some Bad News, Some Good News
The growing use of HPAPIs has created some challenges in the lab, while at the same time offering advantages as well.Emil W. Ciurczak, DoraMaxx Consulting 07.18.17
-
Regulatory Affairs
Data Integrity Guidance Around the World
A look at data integrity controls and the overall framework for a data governance system.James Davidson, Ph.D, Lachman Consultants 07.18.17
-
Entering the Cold Call Zone
Networking’s far side is not for the faint of heartDavid G. Jensen, Contributing Editor 07.18.17
-
Top Indian Firms Expand Base in the U.S.
Goal is to make more drug products in AmericaS. Harachand, Contributing Editor 06.06.17
-
Trends in New Technologies & Budgets
Budget increases in biopharmaceutical industry indicate future growthEric S. Langer, BioPlan Associates 06.06.17
-
21st Century Technologies for Bioprocessing Control
A closer look at the manufacture of biomoleculesEmil W. Ciurczak, DoraMaxx Consulting 06.06.17
-
NSAIDs – Friend or Foe?
Although widely used for years, NSAIDs have side effects that could eventually change their OTC statusAdele Graham-King, Contributing Editor 06.06.17
-
Inspections | Regulatory Affairs
-
Validating Your Decision to Hire
A reference check process you can live withDavid G. Jensen, Contributing Editor 06.06.17
-
Current Trends in Analytical Testing
Improved analytical methods continues to be a current need for nearly every aspect of biopharma manufacturingEric S. Langer, BioPlan Associates 05.09.17
